Cargando…
Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter]
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599866/ https://www.ncbi.nlm.nih.gov/pubmed/34803404 http://dx.doi.org/10.2147/CLEP.S345565 |
_version_ | 1784601034939695104 |
---|---|
author | Andreassen, Bettina K Hektoen, Helga H Axcrona, Karol Langseth, Hilde Stenehjem, Jo S Robsahm, Trude E |
author_facet | Andreassen, Bettina K Hektoen, Helga H Axcrona, Karol Langseth, Hilde Stenehjem, Jo S Robsahm, Trude E |
author_sort | Andreassen, Bettina K |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8599866 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-85998662021-11-19 Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter] Andreassen, Bettina K Hektoen, Helga H Axcrona, Karol Langseth, Hilde Stenehjem, Jo S Robsahm, Trude E Clin Epidemiol Response to Letter Dove 2021-11-08 /pmc/articles/PMC8599866/ /pubmed/34803404 http://dx.doi.org/10.2147/CLEP.S345565 Text en © 2021 Andreassen et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Response to Letter Andreassen, Bettina K Hektoen, Helga H Axcrona, Karol Langseth, Hilde Stenehjem, Jo S Robsahm, Trude E Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter] |
title | Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter] |
title_full | Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter] |
title_fullStr | Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter] |
title_full_unstemmed | Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter] |
title_short | Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter] |
title_sort | prediagnostic serum-25 hydroxyvitamin d and mortality among bladder cancer patients in the janus serum bank cohort: answer to a short comment [response to letter] |
topic | Response to Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599866/ https://www.ncbi.nlm.nih.gov/pubmed/34803404 http://dx.doi.org/10.2147/CLEP.S345565 |
work_keys_str_mv | AT andreassenbettinak prediagnosticserum25hydroxyvitamindandmortalityamongbladdercancerpatientsinthejanusserumbankcohortanswertoashortcommentresponsetoletter AT hektoenhelgah prediagnosticserum25hydroxyvitamindandmortalityamongbladdercancerpatientsinthejanusserumbankcohortanswertoashortcommentresponsetoletter AT axcronakarol prediagnosticserum25hydroxyvitamindandmortalityamongbladdercancerpatientsinthejanusserumbankcohortanswertoashortcommentresponsetoletter AT langsethhilde prediagnosticserum25hydroxyvitamindandmortalityamongbladdercancerpatientsinthejanusserumbankcohortanswertoashortcommentresponsetoletter AT stenehjemjos prediagnosticserum25hydroxyvitamindandmortalityamongbladdercancerpatientsinthejanusserumbankcohortanswertoashortcommentresponsetoletter AT robsahmtrudee prediagnosticserum25hydroxyvitamindandmortalityamongbladdercancerpatientsinthejanusserumbankcohortanswertoashortcommentresponsetoletter |